Print Page

Products found to contain undeclared medicines

Australia: Xiyouji Qingzhi weight loss capsules is found to contain undeclared prescription substance sibutramine
The supply of Xiyouji Qingzhi weight loss capsules in Australia is illegal. However, a number of people in Australia have bought the product online. The Therapeutic Goods Administration (TGA) has tested Xiyouji Qingzhi weight loss capsules and found that: a. it contains the undeclared prescription substance sibutramine (which was the active ingredient in Reductil) - this is despite the claim made on the box that it is a natural product and contains no medicines, b. consumers are advised that sibutramine was a prescription-only medicine supplied in Australia until it was withdrawn in October 2010 after a study showed an increased risk of major cardiac events, and c. the levels of sibutramine contained in the capsules are higher than the levels previously approved by the TGA for prescription sibutramine. Consumers are advised to stop taking Xiyouji Qingzhi weight loss capsules and discard any remaining capsules. If consumers have any concerns arising from the use of this product, consult the health care practitioners.

Please refer to the following website in TGA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Friday, March 9, 2012
Issued at HKT 12:30
Related Information:
The United States: JaDera and Xiyouji Qingzhi Dietary Supplements by Dolphin Int... Posted 2013-06-29
The United States: Public Notification: “XIYOUJI QINGZHI CAPSULE” Contains Hidde... Posted 2013-06-11
Canada: Foreign Product Alert: Lipro Diet Pills; Xiyouji Qingzhi weight loss cap... Posted 2012-05-25